A detailed history of Royal Bank Of Canada transactions in Absci Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 168,851 shares of ABSI stock, worth $626,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
168,851
Previous 238,808 29.29%
Holding current value
$626,437
Previous $735,000 12.24%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.97 - $4.49 $207,772 - $314,106
-69,957 Reduced 29.29%
168,851 $645,000
Q2 2024

Aug 14, 2024

BUY
$2.92 - $6.58 $528 - $1,190
181 Added 0.08%
238,808 $735,000
Q1 2024

Nov 05, 2024

SELL
$3.41 - $5.74 $617 - $1,038
-181 Reduced 0.08%
238,627 $1.36 Million
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $813,663 - $1.37 Million
238,611 Added 1491318.75%
238,627 $1.36 Million
Q4 2023

Feb 14, 2024

BUY
$1.15 - $4.79 $2 - $9
2 Added 14.29%
16 $0
Q3 2023

Nov 14, 2023

SELL
$1.28 - $2.41 $11,585 - $21,812
-9,051 Reduced 99.85%
14 $0
Q2 2023

Aug 14, 2023

BUY
$1.17 - $2.03 $648 - $1,124
554 Added 6.51%
9,065 $13,000
Q1 2023

May 15, 2023

SELL
$1.58 - $3.41 $4,545 - $9,810
-2,877 Reduced 25.26%
8,511 $14,000
Q4 2022

Feb 14, 2023

BUY
$2.0 - $3.58 $5,198 - $9,304
2,599 Added 29.57%
11,388 $23,000
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.83 $5,879 - $9,626
1,993 Added 29.33%
8,789 $27,000
Q2 2022

Aug 15, 2022

SELL
$3.13 - $8.83 $6,635 - $18,719
-2,120 Reduced 23.78%
6,796 $23,000
Q1 2022

May 16, 2022

BUY
$5.87 - $9.46 $24,994 - $40,280
4,258 Added 91.41%
8,916 $75,000
Q4 2021

Feb 14, 2022

BUY
$7.88 - $18.03 $25,168 - $57,587
3,194 Added 218.17%
4,658 $38,000
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $15,181 - $44,344
1,464 New
1,464 $18,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $344M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.